Novozymes Statistics

Total Valuation

Novozymes has a market cap or net worth of GBP 25.17 billion. The enterprise value is 26.39 billion.

Market Cap	25.17B
Enterprise Value	26.39B

Important Dates

The last earnings date was Thursday, May 8, 2025.

Earnings Date	May 8, 2025
Ex-Dividend Date	Apr 4, 2025

Share Statistics

Current Share Class	411.94M
Shares Outstanding	n/a
Shares Change (YoY)	-8.56%
Shares Change (QoQ)	+68.44%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	346.42M

Valuation Ratios

The trailing PE ratio is 65.63 and the forward PE ratio is 30.82.

PE Ratio	65.63
Forward PE	30.82
PS Ratio	7.42
PB Ratio	2.68
P/TBV Ratio	22.23
P/FCF Ratio	49.20
P/OCF Ratio	31.68
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 26.61, with an EV/FCF ratio of 51.59.

EV / Earnings	68.81
EV / Sales	7.72
EV / EBITDA	26.61
EV / EBIT	34.15
EV / FCF	51.59

Financial Position

The company has a current ratio of 1.66, with a Debt / Equity ratio of 0.15.

Current Ratio	1.66
Quick Ratio	1.03
Debt / Equity	0.15
Debt / EBITDA	1.44
Debt / FCF	2.78
Interest Coverage	11.41

Financial Efficiency

Return on equity (ROE) is 6.97% and return on invested capital (ROIC) is 7.25%.

Return on Equity (ROE)	6.97%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	7.25%
Return on Capital Employed (ROCE)	6.64%
Revenue Per Employee	320,776
Profits Per Employee	36,247
Employee Count	10,582
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +12.23% in the last 52 weeks. The beta is 0.54, so Novozymes's price volatility has been lower than the market average.

Beta (5Y)	0.54
52-Week Price Change	+12.23%
50-Day Moving Average	426.15
200-Day Moving Average	428.27
Relative Strength Index (RSI)	74.77
Average Volume (20 Days)	140,348

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novozymes had revenue of GBP 3.39 billion and earned 383.57 million in profits. Earnings per share was 1.32.

Revenue	3.39B
Gross Profit	1.79B
Operating Income	771.06M
Pretax Income	514.32M
Net Income	383.57M
EBITDA	988.57M
EBIT	771.06M
Earnings Per Share (EPS)	1.32

Full Income Statement

Balance Sheet

The company has 208.72 million in cash and 1.42 billion in debt, giving a net cash position of -1.21 billion.

Cash & Cash Equivalents	208.72M
Total Debt	1.42B
Net Cash	-1.21B
Net Cash Per Share	n/a
Equity (Book Value)	9.40B
Book Value Per Share	20.15
Working Capital	648.92M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 794.57 million and capital expenditures -282.93 million, giving a free cash flow of 511.64 million.

Operating Cash Flow	794.57M
Capital Expenditures	-282.93M
Free Cash Flow	511.64M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 52.73%, with operating and profit margins of 22.72% and 11.30%.

Gross Margin	52.73%
Operating Margin	22.72%
Pretax Margin	15.15%
Profit Margin	11.30%
EBITDA Margin	29.12%
EBIT Margin	22.72%
FCF Margin	15.07%

Dividends & Yields

This stock pays an annual dividend of 0.70, which amounts to a dividend yield of 0.15%.

Dividend Per Share	0.70
Dividend Yield	0.15%
Dividend Growth (YoY)	-1.72%
Years of Dividend Growth	n/a
Payout Ratio	54.46%
Buyback Yield	8.56%
Shareholder Yield	8.71%
Earnings Yield	1.52%
FCF Yield	2.03%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on November 28, 2011. It was a forward split with a ratio of 5.

Last Split Date	Nov 28, 2011
Split Type	Forward
Split Ratio	5

Scores

Novozymes has an Altman Z-Score of 5.71.

Altman Z-Score	5.71
Piotroski F-Score	n/a